Portfolio company
LEAH Labs
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops gene-edited cell therapies for dogs with cancer for use by veterinarians.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
Gallant Therapeutics
This company develops mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
ScoutBio
The company develops monoclonal antibodies and gene therapies for pets to treat chronic diseases.
FidoCure
The company provides genomic testing and AI-enabled personalised treatment recommendations for dogs with cancer to veterinarians and pet owners.
Gallant Pet
This biotechnology company develops regenerative stem cell therapies for domestic cats and dogs to treat chronic inflammatory and degenerative conditions.
Gallant
The company develops ready-to-use mesenchymal stromal cell therapies for veterinary professionals to treat inflammatory diseases and promote tissue repair in cats and dogs.
PETDX
This company develops liquid biopsy blood tests for the early detection of cancer in dogs for use by veterinary professionals.
Loyal
This biotechnology firm develops pharmaceutical drugs to extend the healthy lifespan of companion dogs for pet owners and veterinary professionals.